Parag Milk Foods Reports No Deviation in Fund Utilization for Q3 FY26
Parag Milk Foods confirms no deviation in fund utilization for convertible warrants for the quarter ended Dec 31, 2025. INR 40.30 crore was raised on May 23, 2025, for debt reduction, working capital, capex, and general corporate purposes. All utilized funds matched original allocations.
This is a standard regulatory filing and does not involve any new financial information or significant corporate action that would materially impact the company's valuation or operations.
The announcement is a routine compliance filing confirming no deviation in fund utilization, which is a neutral event for the company.
Parag Milk Foods Limited has confirmed that there was no deviation or variation in the utilization of proceeds received from the issuance of Convertible Share Warrants for the quarter ended December 31, 2025. The company raised INR 40.30 crore on May 23, 2025, through a Preferential Issue. The funds were earmarked for Debt Reduction (INR 17.50 crore), Working Capital (INR 7.80 crore), Capital Expenditure (INR 5.00 crore), and General Corporate Purposes (INR 10.00 crore). The statement, reviewed by the Audit Committee and Board of Directors, confirms that the utilized amounts matched the original allocation for all purposes, with no deviation reported.
The statement of no deviation or variation was prepared in accordance with SEBI Master Circular No. HO/49/14/14(7)2025 -CFD- POD2/I/3762/2026 dated January 30, 2026. India Ratings & Research Private Limited was the monitoring agency for these funds. The original objects for fund raising included Debt Reduction, Working Capital, Capital Expenditure, and General Corporate Purposes. The total funds raised were INR 40.30 crore, with a total modified allocation of INR 40.00 crore. The utilized amount for the quarter was INR 40.00 crore, resulting in Nil deviation or variation for the quarter.
What to do with a filing like this
Parag Milk Foods Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Parag Milk Foods Limited. Read the original for the full detail.